ASPM and lung cancer: Suberoylanilide hydroxamic acid significantly enhanced the tumor initiating capacity and the expression of malignant genes such as ASPM in the remaining living ALDH cells, which can suppress the growth of tumor xenografts and decreases the lung cancer stem cell population in vivo [38].